Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Ustekinumab – Treatment for Plaque Psoriasis



Studies conducted to date suggest that ustekinumab is an effective treatment for plaque psoriasis.


  • Discovered and developed by Centocor, ustekinumab (CNTO 1275) is an...

  • Studies conducted to date suggest that ustekinumab is an effective treatment...

  • A variety of tools have been used to assess the severity of plaque psoriasis...

Back to Project Details



Related Projects

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator
Developed by French pharmaceutical company NicOx, naproxcinod (HCT 3012)...

Lyrica (Pregabalin) - New Gabapentinoid with Wide
Developed by Pfizer, pregabalin, marketed under the brand name Lyrica, is...

See all projects


Follow Us:
Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.